Intracellular bacterial proteins and nucleic acids

Intracellular bacterial proteins and nucleic acids represent a broad class of molecular targets essential for the survival, replication, and virulence of bacteria that reside within host cells. These components include vital machinery such as the bacterial ribosome, DNA gyrase, and RNA polymerase, which are the primary targets for various classes of antibiotics like macrolides, fluoroquinolones, and rifamycins (StatPearls, https://www.ncbi.nlm.nih.gov/books/NBK482450/). Beyond their role as antibiotic targets, these molecules function as pathogen-associated molecular patterns (PAMPs) that are recognized by the host's innate immune system through pattern recognition receptors (PRRs) like cGAS, AIM2, and certain Toll-like receptors (Nature Reviews Immunology, https://www.nature.com/articles/nri.2017.110). Recognition of these intracellular components triggers inflammatory responses and antimicrobial defenses, such as the production of Type I interferons and the assembly of inflammasomes. Consequently, they are central to both the pathogenesis of intracellular infections, such as Tuberculosis and Legionellosis, and the therapeutic strategies designed to eradicate them (Microbiology and Molecular Biology Reviews, https://journals.asm.org/journal/mmbr/article-abstract/75/3/484). However, targeting these molecules requires drugs to effectively penetrate host cell membranes and can lead to challenges such as the development of antimicrobial resistance or interference with host mitochondrial functions. The detection of these nucleic acids and proteins also serves as a critical diagnostic marker for identifying the presence and viability of intracellular pathogens in clinical settings.

Other names

Bacterial PAMPsIntracellular bacterial componentsBacterial macromoleculesIntracellular bacterial ligandsIntracellular bacterial nucleic acids and proteins

Drugs targeting these components typically act by binding to bacterial enzymes or ribosomes to inhibit essential processes such as DNA supercoiling (fluoroquinolones), RNA synthesis (rifamycins), or protein translation (macrolides and tetracyclines). Additionally, host immune sensors recognize these molecules to trigger defensive signaling pathways.